partager sur facebook

High Quality Phenotypes


Close proximity of clinical research units with care departments will ensure fast translation of clinical research findings into routine care practice.

This will be done through improvement of clinical data collection, development of new phenotypes through ICAN-Investigation clinical core facility and long-term follow up in order to validate hypotheses on prediction/progression of CM disorders.

To illustrate this objective a Reference Center is being set up to evaluate the biologic response to oral antiplatelet agents and its relation to pharmacogenetics in patients with adverse ischemic events despite treatment compliance.